Semaglutide vs Tirzepatide: Comparative Analysis of GLP-1 Receptor Agonist Efficacy for Weight Loss and Glycemic Control Research indicates that Tirzepatide, a dual GIP/GLP-1 receptor agonist, demonstrates superior weight loss efficacy compared to Semaglutide, a GLP-1-only agonist, in head-to-head clinical trials
Saponaro C, Gaggini M, Gastaldelli A
The Precision Peptide Genetic Test reveals predispositions in antioxidant enzyme pathways that may inform oxidative stress context
The 7 Best Vegan Protein Powders for Optimal Muscle Growth Premium Complete Protein Blends 1
There are several limitations in the present study
Final thoughts: GLP-1s need a strategy, not just coverage Covering Wegovy and other GLP-1s can be a high-impact move but only if its done right